Downregulation and/or Release of NKG2D Ligands as Immune Evasion Strategy of Human Neuroblastoma
Neuroblastoma (NB) is a pediatric extracranial tumor characterized by downregulation of human leukocyte antigen class I and defects of the antigen processing machinery, two features that make it an appropriate target for natural killer (NK)-mediated lysis. NKG2D is an activating immunoreceptor expr...
Main Authors: | Lizzia Raffaghello, Ignazia Prigione, Irma Airoldi, Marta Camoriano, Isabella Levreri, Claudio Gambini, Daniela Pende, Alexander Steinle, Soldano Ferrone, Vito Pistoia |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2004-09-01
|
Series: | Neoplasia: An International Journal for Oncology Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1476558604800344 |
Similar Items
-
Pediatric Tumors-Mediated Inhibitory Effect on NK Cells: The Case of Neuroblastoma and Wilms’ Tumors
by: Andrea Pelosi, et al.
Published: (2021-05-01) -
Impairment of NKG2D-Mediated Tumor Immunity by TGF-β
by: Mariya Lazarova, et al.
Published: (2019-11-01) -
Immunosuppressive microenvironment in neuroblastoma
by: Vito ePistoia, et al.
Published: (2013-06-01) -
Immunotherapeutic Strategies for Neuroblastoma: Present, Past and Future
by: Fabio Morandi, et al.
Published: (2021-01-01) -
MYCN is an immunosuppressive oncogene dampening the expression of ligands for NK-cell-activating receptors in human high-risk neuroblastoma
by: Elisa Brandetti, et al.
Published: (2017-06-01)